type 1 diabetes Clinical Trials and Research
Also known as: juvenile diabetes, insulin-dependent diabetes, t1d, autoimmune diabetes, diabetes mellitus type 1 · ICD-10: E10
Type 1 diabetes is an autoimmune disease where the body's immune system mistakenly attacks and destroys insulin-producing cells in the pancreas. Clinical trial research focuses on preventing the disease, slowing its progression, improving insulin delivery methods, and finding potential cures. Find a Trial helps patients search for active studies.
Search type 1 diabetes trials →
Common questions about type 1 diabetes clinical trials
Who can participate in type 1 diabetes clinical trials?
Eligibility criteria vary greatly by study, often including age, disease duration, and specific health markers. Researchers use these criteria to ensure patient safety and gather relevant data. Information on specific criteria for individual studies is available on ClinicalTrials.gov.
What are the different phases of type 1 diabetes clinical trials?
Clinical trials typically progress through phases, from early-stage safety testing (Phase 1) to larger studies evaluating effectiveness and comparing new interventions (Phases 2-3). Phase 4 studies monitor long-term effects after approval. This structured approach helps ensure new treatments are safe and effective, as tracked on ClinicalTrials.gov.
Do clinical trials for type 1 diabetes cost money to participate?
Generally, study-related medical care and interventions in a clinical trial are provided at no cost to participants. However, some trials may not cover all routine medical care or travel expenses. Patients should discuss potential costs with the research team, as detailed on ClinicalTrials.gov.
What are current research directions in type 1 diabetes clinical trials?
Current research explores preventing the immune attack, developing artificial pancreas systems, and investigating cell-based therapies like islet transplantation. Studies also focus on new insulin formulations and glucose monitoring technologies. Data from ClinicalTrials.gov and NIH RePORTER highlight these active areas.
What types of interventions are studied in type 1 diabetes trials?
Interventions range from new insulin delivery devices and glucose monitoring systems to immunotherapies aimed at preserving beta cell function. Researchers also study lifestyle modifications and educational programs. These diverse approaches are documented on ClinicalTrials.gov.
What biomarkers are important in type 1 diabetes clinical trials?
Key biomarkers include C-peptide levels, which indicate remaining insulin production, and autoantibodies (like GAD65, IA-2, IAA, ZnT8), which signal an ongoing autoimmune attack. Glucose levels and HbA1c are also crucial for monitoring disease control. These are often measured in studies listed on ClinicalTrials.gov.
What are common reasons someone might be excluded from a type 1 diabetes trial?
Common exclusion criteria can include significant kidney or heart disease, pregnancy, or other autoimmune conditions that might interfere with study results or participant safety. Recent changes in medication or unstable glucose control might also be reasons for exclusion. Specifics are found on ClinicalTrials.gov.
Are there clinical trials focused on preventing type 1 diabetes or its progression?
Yes, many trials investigate strategies to prevent type 1 diabetes in at-risk individuals or slow its progression in newly diagnosed patients. These often involve immunotherapies designed to modulate the immune system. Details on such prevention studies are available on ClinicalTrials.gov and NIH RePORTER.
How to find a type 1 diabetes trial that fits you
- Describe your type 1 diabetes situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all type 1 diabetes trials →